Session Information
AABB Annual Meeting and CTTXPO 2012
Click here to go to the previous page
The Science of Freezing Cellular Products
Track
:
TC - Technical/Clinical
Program Code:
9211-TC-CT
Date:
Sunday, October 7, 2012
Time:
10:30 AM to 12:00 PM
EST
Location:
Ballroom West
DIRECTOR
:
Aby J. Mathew, PhD, Senior Vice President & Chief Technology Officer, BioLife Solutions
MODERATOR
:
Aby J. Mathew, PhD, Senior Vice President & Chief Technology Officer, BioLife Solutions
SPEAKER
(S):
Dr. Jason Acker, PhD, MBA, Senior Development Scientist, Canadian Blood Services
Erik Woods, PhD, President, Cook General Biotechnology
Michael Creer, MD, Director, Clinical Laboratories and Chief, Clinical Pathology, Penn State Hershey Medical Center
Description
This session will review the basic scientific principles governing the successful cryopreservation of current cellular therapy/transfusion medicine products. A focus will be on limits that cell biophysics, ice crystal nucleation and growth, cryoprotectant toxicity and water and cryoprotectant permeability have on the development of a successful cryopreservation protocol. The session will be delivered using a "standard" cryopreservation protocol as the backdrop from which the basic scientific principles will be discussed. Furthermore, multiple cryopreservation freezing curve results that led to positive and negative cellular therapy product results will be presented. Analysis and interpretation of the data, failure analysis of the cryopreservation issues and clinical relevance will be offered. This session is related to a project of the Product Manufacturing and Testing (PMAT) Subsection of the AABB Cellular Therapy Section.
Jason Acker did not consent to presentation capturing and recording.
Jason Acker did not consent to presentation capturing and recording.
- Present data from multiple clinically related cryopreservation freezing curve issues and discuss analysis/interpretations of the freezing curve issues and clinical relevance.
- Provide a summary of the key advances in cryobiology that resulted in the current cellular therapy and transfusion medicine cryopreservation protocols.
- Summarize the scientific basis for the critical steps in clinical cryopreservation protocols to provide end users with a more complete understanding of the need to consider many factors when designing, validating and implementing a cryopreservation protocol.
| CE Category | CE Value |
|---|---|
| California Clinical Laboratory Personnel | 1.5 |
| California Nurse | 1.8 |
| Florida Laboratory Personnel | 1.8 |
| General Attendee | 1.5 |
| Physician | 1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
Online Access
(Code: 9211-TC-CTAM/9211-TC-CTM/9211-TC-CTA/9211-TC-CT)
Annual Meeting Attendee/AABB Member:$25 USD
Non-Attendee/AABB Member:$40 USD
Annual Meeting Attendee/Non AABB Member:$40 USD
Non-Attendee/Non AABB Member $50 USD - Your Price
This session is a part of:
This session is a part of:
 | Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or reproduction of any materials herein is strictly prohibited. |  |